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Background: Asthma is a frequent chronic inflammatory disease of the airways, and the assessment of
health-related quality of life (HrQoL) is important in both research and routine care. Various asthma-specific
measures of HrQoL exist but there is uncertainty which measures are best suited for use in research and routine
care. Therefore, the aim of the proposed research is a comprehensive systematic assessment of the measurement
properties of the existing measures that were developed to measure asthma-specific quality of life.
Methods/design: This study is a systematic review of the measurement properties of asthma-specific measures of
health-related quality of life. PubMed and Embase will be searched using a selection of relevant search terms.
Eligible studies will be primary empirical studies evaluating, describing or comparing measurement properties of
asthma-specific HRQL tools. Eligibility assessment and data abstraction will be performed independently by two
reviewers. Evidence tables will be generated for study characteristics, instrument characteristics, measurement
properties and interpretability. The quality of the measurement properties will be assessed using predefined criteria.
Methodological quality of studies will be assessed using the COnsensus-based Standards for the selection of health
Measurement INstruments (COSMIN) checklist. A best evidence synthesis will be undertaken if more than one study
have investigated a particular measurement property.
Discussion: The proposed systematic review will produce a comprehensive assessment of measurement properties
of existing measures of asthma-specific health-related quality of life. We also aim to derive recommendations in
order to help researchers and practitioners alike in the choice of instrument.
Trial registration: PROSPERO registration number: CRD42014010491.
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Asthma is a chronic inflammatory disease with variable
airway obstruction, characterized by episodes of cough-
ing, wheezing, breathlessness and chest tightness. It is
estimated that around 300 million people worldwide suf-
fer from asthma and that globally asthma accounts for
about one in every 250 deaths [1]. By 2025, there may be
100 million more people with asthma. The number of
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article, unless otherwise stated.comparable to the DALYs lost for diabetes, cirrhosis of
the liver or schizophrenia.
Various medical and non-medical interventions exist
to alleviate asthma, many of which have been assessed in
randomized controlled trials. Because different outcome
measures of various domains (such as disease severity,
quality of life, symptoms) are used in different trials, the
findings from these trials are difficult to compare. The
lack of standardized asthma outcome measurement
currently makes truly evidence-based decision making
difficult, if not impossible.
One frequently used outcome is ‘health-related quality
of life’ (HRQoL) which is a patient-reported outcome
(PRO). According to the definition of the U.S. Food andntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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port of the status of a patient's health condition that
comes directly from the patient, without interpretation
of the patient's responses by a physician or anyone else’
[2]. Several reviews of PRO instruments for asthma have
been conducted.
A published structured review identified six common
asthma-specific quality-of-life measures: the Juniper
Asthma Quality of Life Questionnaire (AQLQ-J) [3],
the Sydney Asthma Quality of Life Questionnaire
(AQLQ-S) [4], the Living with Asthma Questionnaire
(LWAQ) [5], the St George's Respiratory Questionnaire
(SGRQ) [6,7], the Quality of Life for Respiratory Illness
Questionnaire (QOL-RIQ) [8] and the Rhinasthma ques-
tionnaire [9]. The measures were reviewed using seven
different criteria: conceptual and measurement model,
reliability, validity, interpretability, burden, administration
format and translations. The review concluded that the
instruments differed in almost all criteria, and therefore, it
cannot be assumed that they measure the same thing. The
authors recommend to select those questionnaires that
were designed for asthma and that do not assess symp-
toms as part of quality of life (QoL). These requirements
are fulfilled by the Sydney Asthma QoL Questionnaire
(AQLQ-S) [4] and the Living with Asthma Questionnaire
(LWAQ) [5]. However, it is also stated that it remains
unclear which of the questionnaires best reflects patient
perception of QoL.
The Patient-reported Outcome Measurement Group
(POMG) in England completed a comprehensive struc-
tured review of patient-reported outcome measures for
people with asthma and provided recommendations to
the Department of Health [10]. The difference to the
structured review is that it not only encompasses
asthma-specific quality-of-life measures, but also measures
of health status, asthma control, utilities and symptoms.
Twenty-two asthma-specific measures were evaluated.
Based on the volume of evaluations and good measurement
and operational characteristics, the original Juniper Asthma
Quality of Life Questionnaire [3], the standardized Juniper
Asthma Quality of Life Questionnaire [11] and the mini
Juniper Asthma Quality of Life Questionnaire [12] as well
as the Sydney Asthma Quality of Life Questionnaire [4]
were presented to a multidisciplinary panel for discussion.
Based on appraisal of evidence by the POMG and taking
account of ratings and comments from the panel, the mini
AQLQ was recommended as an asthma-specific instru-
ment. Its ease of use and patient acceptability as well as
the good concordance between postal and supervised ad-
ministration was considered to be an important character-
istic for measuring outcomes in NHS clinical care.
The third important review comes from the USA. In
the light of a lack of adequate outcomes standardization,
several National Institutes of Health (NIH) organizationsthat support asthma research as well as the Agency for
Healthcare Research and Quality in the US agreed to a drive
towards outcome standardization. As part of this effort,
the published documentation relating to asthma-specific
quality-of-life measures was reviewed [13]. In the review,
the existing instruments were classified as follows:
 Core outcomes: selective set of asthma outcomes to
be considered by participating NIH institutes and
other federal agencies as requirements for institute-/
agency-initiated funding of clinical trials and large
observational studies in asthma
 Supplemental outcomes: asthma outcomes for which
standard definitions can or have been developed,
methods for measurement can be specified, and
validity has been proved but whose inclusion in
funded clinical asthma research will be optional
 Emerging outcomes: asthma outcomes that have the
potential to (1) expand and/or improve current
aspects of disease monitoring and (2) improve
translation of basic and animal model-based
asthma research into clinical research. Emerging
outcomes may be new or may have been previously
used in asthma clinical research, but they are not
yet standardized and require further development
and validation
The US review identified 9 instruments for adults, the
ABP [14], the Asthma Impact Survey [15], the AQLQ-J-s
[11], the mini AQLQ-J [12], the LWAQ [16], the modified
AQLQ-S [17], the Asthma Short Form [18], the SGRQ
[6,7] and the AQ-20 [17].
None of these qualified as core outcome because they
predominantly measured indicators of asthma control
(symptoms and/or functional status), failed to provide
a distinct, reliable score measuring all key dimensions
of the intended construct and/or lacked adequate psy-
chometric data.
All three reviews have failed to perform a systematic
literature search and have not included a systematic assess-
ment of the methodological quality of the included studies.
The proposed review will therefore systematically assess the
measurement properties of asthma-specific quality-of-life
measures and include an assessment of the methodological
quality of all included studies.
Methods/design
This study is a systematic review of the measurement
properties of asthma-specific measures of health-related
quality of life.
Eligible measures
All measures which are specifically designed to measure
health-related quality of life in asthma are eligible.
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Inclusion criteria
A study will be included if it is a full text paper, published
in English and describes the development (‘inauguration
paper’) and/or evaluation of the measurement proper-
ties (‘validation paper’) of an asthma-specific measure
of HRQoL. The study population should be adults
(≥18 years) with asthma. The study should be published as
a full text paper and the instrument should be a self-report
questionnaire.
Exclusion criteria: Articles reporting on interview in-
struments or instruments for proxies will not be con-
sidered for the purpose of this review. Articles that
report an eligible measure, e.g. as an outcome in a clin-
ical trial without any explicit validation will not be
considered eligible.
Literature search
A systematic literature search will be performed in
PubMed and EMBASE. Blocks of search terms will be
used relating to the following aspects:
 Construct of interest (asthma-specific health-related
quality of life): here, the broad search term ‘quality
of life’ will be used.
 Target population (adult asthma patients): here,
different combinations will be used like ‘allergic’ or
‘atopic’ or ‘bronchial’ and each will be combined
with ‘asthma’. The search will be limited to humans.
 Measurement properties: The highly sensitive
PubMed search filter for finding studies on
measurement properties developed by Terwee
et al. will be used to identify relevant articles [19].
This filter has a sensitivity of 97.4% and a precision
of 4.4%. A selection of relevant search terms will
be used in EMBASE, which has been used before
in reviews.
For each of these search strategies, a thorough list of
synonyms will be collated using index terms (e.g. MESH
terms in PubMed) linked with other free text words.
The synonyms will be combined with the conjunction
‘OR’. After that, the searches designed according to the
three main aspects will be combined with ‘AND’ in
order to get to the list of publications from which the
relevant ones will be picked. A further search will be
conducted with the names of instruments found in the
original search. These names should be combined with
AND with the requirements for the target population
and measurement properties. The references of all the
included relevant articles will also be screened. In
addition, websites of relevant professional organiza-
tions and institutions will be searched. For all searches,
search dates will be provided in the review.Study selection
In a first phase, titles and abstracts will be assessed for
eligibility. Full text articles will be obtained for the
remaining abstracts and again be assessed for eligibility.
Each citation will be judged for eligibility independently
by two reviewers. Disagreements will be resolved by dis-
cussion of all reviewers.
Data extraction
Two reviewers will independently extract data from each
article included. Relevant data from all included articles
will be summarized in evidence tables. Evidence tables
will contain the following information: characteristics of
the instrument (name of measure, domains measured,
number of items), characteristics of the study population
(geographical location, gender, age, co-morbidities),
results for conceptual models and measurement prop-
erties (reliability, validity, responsiveness to change
according to Table 1) and results for interpretability
(including minimal important difference). The evidence
tables will be pilot-tested.
Assessment of the measurement properties of instruments
The predefined quality criteria for rating the measure-
ment properties of instruments recommended by the
COnsensus-based Standards for the selection of health
Measurement INstruments (COSMIN) group will be
used to assess the measurement properties of the measures
[20] (Table 1). These relate to the following measurement
properties and aspects of measurement properties: reliabil-
ity (internal consistency, measurement error, reliability),
validity (content validity, structural validity, hypothesis
testing) and responsiveness. In addition, we will consider
whether the development of any instrument included in
the systematic review was based on an a priori conceptual
framework/model.
Assessment of the methodological quality of
included studies
The COSMIN checklist [21-23] will be used to evaluate
the methodological quality of included studies. In the
COSMIN checklist (www.cosmin.nl), four domains are
distinguished (reliability, validity, responsiveness and
interpretability) with related measurement properties
and aspects of measurement properties. For each of the
measurement properties, the COSMIN checklist con-
sists of 5–18 items covering methodological standards
(organized in nine boxes for the nine measurement
properties). In addition, each item can be scored on a
four-point scale (i.e. ‘poor’, ‘fair’, ‘good’, ‘excellent’). Tak-
ing the lowest rating for each item in one box, an over-
all quality score (poor, fair, good, excellent) is obtained for
each measurement property separately.
Table 1 Quality criteria for measurement properties
Property Rating Quality criteria
Reliability
Internal consistency + (Sub)scale unidimensional AND Cronbach's alpha(s) ≥0.70
? Dimensionality not known OR Cronbach's alpha not determined
− (Sub)scale not unidimensional OR Cronbach's alpha(s) <0.70
Measurement error + MIC > SDC OR MIC outside the LOA
? MIC not defined
− MIC≤ SDC OR MIC equals or inside LOA
Reliability + ICC/weighted kappa ≥0.70 OR Pearson's r≥ 0.80
? Neither ICC/weighted kappa, nor Pearson's r determined
− ICC/weighted kappa <0.70 OR Pearson's r < 0.80
Validity
Content validity + All items are considered to be relevant for the construct to be measured, for the target
population and for the purpose of the measurement AND the questionnaire is considered
to be comprehensive
? Not enough information available
− Not all items are considered to be relevant for the construct to be measured, for the target
population and for the purpose of the measurement OR the questionnaire is considered
not to be comprehensive
Construct validity
Structural validity + Factors should explain at least 50% of the variance
? Explained variance not mentioned
− Factors explain <50% of the variance
Hypothesis testing + Correlation with an instrument measuring the same construct ≥0.50 OR at least 75% of
the results are in accordance with the hypotheses AND correlation with related constructs
is higher than with unrelated constructs
? Solely correlations determined with unrelated constructs
− Correlation with an instrument measuring the same construct <0.50 OR <75% of the
results are in accordance with the hypotheses OR correlations with related constructs are
lower than with unrelated constructs
Responsiveness
Responsiveness + Correlation with changes on instruments measuring the same construct ≥0.50 OR at least
75% of the results are in accordance with the hypotheses OR AUC ≥0.70 AND correlation
with changes in related constructs are higher than with unrelated constructs
? Solely correlations determined with unrelated constructs
− Correlations with changes on instruments measuring the same construct <0.50 OR <75%
of the results are in accordance with the hypotheses OR AUC <0.70 OR correlations with
changes in related constructs are lower than with unrelated constructs
Plus sign indicates positive rating; question mark, indeterminate rating and minus sign, negative rating. MIC minimal important change, SDC smallest detectable
change, LOA limits of agreement, ICC intraclass correlation coefficient, AUC area under the curve.
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If several studies exist for one measure, findings will be
synthesized by combining them, based on number and
methodological quality of the studies and consistency of
results as previously suggested [24]. The criteria for syn-
thesizing evidence are summarized in Table 2.
Discussion
The proposed systematic review will produce a comprehen-
sive assessment of measurement properties of existingmeasures of asthma-specific health-related quality of life.
We will highlight the major findings of the review and de-
scribe evidence in terms of grade supporting or not sup-
porting the use of any given asthma-specific HRQL tool.
We will highlight problems and limitations that we will find
across the reviewed tools. The strengths and limitations in
the identified evidence (e.g. relating to amount of evidence,
validity, feasibility) will be presented and discussed. Finally,
we will report about strengths and limitations of our review
and highlight future research and policy implications.
Table 2 Levels of evidence for the overall quality of a
measurement property
Level Rating Criteria
Strong +++ or −−− Consistent findings in multiple studies of
good methodological quality OR in one
study of excellent methodological quality
Moderate ++ or −− Consistent findings in multiple studies of
fair methodological quality OR in one
study of good methodological quality
Limited + or − One study of fair methodological quality
Conflicting +/− Conflicting findings
Unknown ? Only studies of poor methological quality
Plus sign indicates positive rating; question mark, indeterminate rating and
minus sign, negative rating.
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help researchers and practitioners alike in the choice of
instrument. For each instrument identified in the review,
a standardized recommendation for usage or required
future validation work will be made depending on the
best evidence synthesis.
Four categories of recommendation will be made as
follows:
a) Outcome measure achieves positive ratings (at least ‘+’)
for all measurement properties and is recommended
for use.
b) Outcome measure achieves positive ratings (at least ‘+’)
for at least two measurement properties, but
performance in all other required measurement
properties is unclear, so that the outcome measure has
the potential to be recommended in the future
depending on the results of further validation studies.
c) Outcome measure has low quality in at least one
measurement property (at least one ‘−’ rating) and
therefore is not recommended to be used any more.
d) Outcome measure has (almost) not been validated.
Its performance in all or most relevant
measurement properties is unclear, so that it is not
recommended to be used until further validation
studies clarify its quality.
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